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A B S T R A C T
We herein present the case of a 70-year old lady with probable arrhythmogenic right 
ventricular cardiomyopathy (ARVC) and recurrent episodes of syncope. She was re-
ferred to our department due to an episode of sustained ventricular tachycardia (VT) 
which caused hemodynamic collapse and was converted electrically. During diagnos-
tic investigation, echocardiography revealed evidence of right ventricular dysfunction. 
She underwent risk stratification and sustained monomorphic VT was easily induced 
during an electrophysiology study. An implantable cardioverter-defibrillator (ICD) 
device was subsequently implanted, but she died suddenly three months later. Interro-
gation of the ICD device did not reveal any arrhythmic event and death was attributed 
to carbon monoxide poisoning.
I N T R O D U C T I O N
Sudden cardiac death (SCD) refers to the sudden cessation of cardiac activity with 
hemodynamic collapse occurring in a short time period (generally within 1 hour of 
symptom onset) in a person with known or unknown cardiac disease. Most cases of 
SCD are related to cardiac arrhythmias. SCD accounts for approximately 15% of the 
total mortality in industrialized countries.1
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an underrecognized 
clinical entity characterized by ventricular arrhythmias and a specific ventricular 
pathology. It is a leading cause of sudden death among young athletes, although the 
condition can affect people of all ages and activity levels. Its prevalence in the general 
population is estimated to be approximately 1:1000.2
C A S E  R E P O R T
A 70-year-old Caucasian female was hospitalized for acute dyspnea, associated with 
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AbbreviAtions
ARVC = arrhythmogenic right ventricular 
cardiomyopathy 
CAD = coronary artery disease 
CMRI = cardiac magnetic resonance 
imaging 
ECG = electrocardiogram
EPS = electrophysiology study 
ICD = mplantable cardioverter 
defibrillator 
LBBB = left bundle branch block 
SAECG = signal averaged ECG 
SCD = sudden cardiac death 
VT = ventricular tachycardia 
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a hypertensive crisis, in a local hospital. Upon discharge she 
experienced an episode of sustained ventricular tachycardia 
(VT) and subsequent hemodynamic collapse. The tachycar-
dia was converted with a direct current shock of 360 joules 
delivered via an external defibrillator. Subsequently, she was 
readmitted and then transferred to our tertiary cardiology 
department for further investigation. Six years earlier she 
had suffered a similar episode and during that hospitalization 
she had undergone coronary catheterization with no signs of 
coronary artery disease (CAD). 
Her past medical history was remarkable for hypertension, 
diabetes mellitus, dyslipidemia and thyroidectomy, receiving 
TABlE 1. Oral Medications
Medication Dose
Lisinopril 20 mg qd
Furosemide 40 mg qd
Carvedilol 6.25 mg bid
Amiodarone 200 mg qd
Aspirin 100 mg qd
Simvastatin 20 mg qd
Metformin 850 mg qd
Glimepiride 4 mg qd
Levothyroxine 0.1 μg qd
bid = twice daily; qd = once daily
FIgURE 1. Patient’s baseline 
electrocardiogram (ECG) show-
ing a left bundle branch block 
(LBBB).
respective therapies (Table 1). She was also taking carvedilol, 
lisinopril, and furosemide for hypertension and was recently 
placed on amiodarone, right after the episode of sustained 
VT. The patient had a strong family history of SCD, as all 
three of her siblings had died suddenly at ages varying from 
32 to 55 years old.
On physical examination, the patient was afebrile, with a 
blood pressure of 120/80 mmHg and a heart rate of 60 beats 
per minute. Her clinical examination and chest x-ray were 
unremarkable. ECG showed sinus rhythm and prolonged 
QRS duration, with left bundle branch block (LBBB) pattern 
(Figure 1). 
No particular findings were noted on her basic laboratory 
testing, which included complete cell blood count, glucose and 
electrolyte levels, kidney and liver function tests and lipid pro-
file. Thyroid-stimulating hormone levels were within normal 
range and cardiac troponin-I was only traceable (0.09 ng/ml). 
Echocardiography revealed mild dilatation of the left 
atrium and mild concentric hypertrophy of the left ventricle, 
along with mild diastolic dysfunction. Evidence of systolic and 
diastolic dysfunction of the right ventricle were present and 
the right ventricular free wall was found to be hypertrophic 
and echodense. Ejection fraction was measured to be approxi-
mately 45% by cardiac magnetic resonance imaging (CMRI), 
but the exam did not elicit any other particular findings. More 
specifically, other than a moderate left atrial dilatation and a 
mild left ventricular hypertrophy, no areas of abnormal signal 
or gadolinium enhancement were spotted in either the left or 
the right ventricle, and no diffuse or segmental wall motion 
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abnormalities were noted in the left ventricular myocardium.
Due to the history of sustained VT, further investigation 
and risk stratification for SCD was deemed necessary, as there 
was a discrepancy between echocardiographic and CMRI find-
ings. One episode of sinus pause was identified on a 24-hour 
holter monitor with duration of 1.8 seconds along with multiple 
premature ventricular complexes (>1500) (Figure 2). Signal 
averaged ECG (SAECG) was positive for late potentials, but 
with limited value due to underlying LBBB (Figure 3). Fur-
ther investigation included interventional testing. Coronary 
angiography revealed patent coronary arteries. During an 
electrophysiology study (EPS), monomorphic sustained VT 
was induced with a single premature stimulus delivered at 
the right ventricular apex and was reverted with overdrive 
pacing (Figures 4a, 4b and 4c). Interestingly, right after the 
conversion of the arrhythmia, the patient had evidence of 
2:1 atrioventricular block (Figure 4d) causing hemodynamic 
instability and requiring admission to the intensive care unit 
and the insertion of a temporary pacemaker. Based on these 
findings, a decision was then made to implant a cardioverter 
defibrillator (ICD) device, which was performed successfully 
on the following day (Figure 5). 
Two months later, the patient’s husband called their chil-
dren and asked for help, as the patient had a new episode of 
syncope. Upon their arrival, both parents were found dead, 
with a cherry-red discolouration in their skin. Device interro-
FIgURE 2. Holter monitoring re-
vealed only a non-significant pause of 
1.8 sec during sleep. 
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FIgURE 3. Signal averaged ECG was positive for late potentials with use of modified criteria, which though remain questionable 
due to underlying LBBB.
gation in the patient did not reveal any arrhythmic event and 
the ICD had not delivered any mode of therapy (Figure 6). 
This incident occurred just one week after the patient’s last 
follow up visit in the outpatient device clinic, where sensing 
parameters of the ICD were found normal. The simultaneous 
death of the patient and her husband was finally attributed 
to carbon monoxide poisoning, as the couple were using a 
brazier for heating.
D I S C U S S I O N
In this case, the diagnosis of ARVC could not be estab-
lished according to the task force criteria. In more detail, 
the patient had an episode of VT with LBBB morphology, 
according to the report from the hospital from which she was 
transferred to our department, and family history consistent 
with SCD due to suspected ARVC. The regional right ven-
tricular hypokinesia on echocardiography raises suspicion for 
right ventricular pathology but does not fulfill the diagnostic 
criteria. The presence of late potentials on SAECG could not 
be considered a criterion, due to the presence of LBBB.3-4 
On the other hand, no alternative diagnosis seemed more 
appropriate for this case. Coronary artery disease had been 
ruled out by coronary angiography. There was no evidence 
of other types of cardiomyopathy, congenital heart disease, 
or of significant valvular disease on both imaging studies 
(echocardiography and CMRI). The findings from the ECG 
were not compatible with preexcitation syndrome or a chan-
nelopathy associated with SCD. Idiopathic right ventricular 
tachycardia could be an alternative diagnosis, but the history 
of resuscitation, the echocardiographic findings, the positive 
family history for SCD and the easy induction of VT during 
EPS, favor the diagnosis of ARVC over idiopathic right ven-
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FIgURE 4. During the electrophysiology study (EPS), sustained monomorphic ventricular tachycardia (SuVT) was easily induced 
with the application of one ventricular extrastimulus at the right ventricular apex (a & b). The tachycardia was terminated with 
overdrive ventricular pacing and sinus rhythm (SR) was restored (c). However, shortly after sinus rhythm was restored, 2:1 atrioven-
tricular block developed (d).
FIgURE 5. Chest X-ray after ICD implantation indicating two endocar-
dial leads, one J-atrial pacing (placed at the right atrial appendage) and 
one pacing/defibrillating ventricular lead placed at the right ventricular 
apex. The ICD pulse generator is placed at the left infraclavicular area. 
ICD = implantable cardioverter defibrillator.
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tricular tachycardia.5
The interesting fact is that, despite high clinical suspicion 
for cardiomyopathy, the diagnosis of AVRC could not be es-
tablished according to current criteria and at the same time the 
patient was at high risk for SCD, according to risk stratification 
with EPS. This underlines the fact that even patients with only 
a few minor criteria could still be at high risk.
There is a high incidence of ventricular arrhythmias in 
ARVC patients, which is estimated to be 23% in those with 
mild disease, 82% with moderate and practically in all patients 
with severe disease.6 However, ARVC presents with syncope 
less frequently, with an overall incidence of 32%,7 and should 
be included in the differential diagnosis of syncope, especially 
in children and adolescents. 
The 2006 ACC/AHA/ESC guidelines suggest the implanta-
tion of an ICD device in patients with documented sustained 
VT or ventricular fibrillation, for secondary prevention, just 
like in our case, and in those patients who are felt to be at 
high risk for primary prevention.8 Nonetheless, what initially 
seemed to be a failure of an appropriately implanted ICD 
device to deliver the necessary therapy, it turned out to be the 
result of an unexpected environmental hazard. 
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FIgURE 6. Post mortem ICD device interrogation indicated no 
detectable arrhythmias.
